These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Inhibition of insulin binding by concanavalin-A.
    Author: Blackard WG, Small E, Luderman C.
    Journal: Metabolism; 1980 Jul; 29(7):691-7. PubMed ID: 6991862.
    Abstract:
    Prolonged incubation of IM-9 lymphoblastoid cells with concanavalin-A (Con-A) reduces insulin binding at concentrations of the lectin that neither agglutinate cells nor acutely inhibit insulin binding. Scatchard plot analysis suggested that Con-A treatment reduces insulin receptor number. Con-A-induced reduction in insulin binding resembles insulin "down regulation" in the time required for appearance and reversal of the binding alteration. The effect of Con-A on insulin binding was inhibited when the sugar alpha-methyl mannoside was incorporated into the incubation medium at the same time as Con-A. Even when the sugar was added after hours of Con-A exposure, the depressed insulin binding was reversed proportional to the reduction of Con-A binding to the cells by the sugar. This latter observation suggests steric hindrance as the mechanism for Con-A-induced reduction in insulin binding. The slow association rate of Con-A to the cells under the conditions of the experiments probably explains the prolonged exposure time to Con-A required for inhibition of insulin binding. Additional support for steric hindrance was observed in experiments in which insulin was "trapped" on cells after exposure to Con-A. Bivalent succinyl Con-A was only 10% as effective as the natural tetravalent lectin in reducing insulin binding. Cytoskeleton and protein synthesis inhibitors failed to alter the Con-A-induced reduction in insulin binding.
    [Abstract] [Full Text] [Related] [New Search]